The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification

Molecular Immunology

Volumn 47, Issue 2-3, 2009, Pages 373-380

  Harboe, Morten ^a   Garred, Peter ^b   Karlstrøm, Ellen ^a   Lindstad, Julie K ^a   Stahl, Gregory L ^c   Mollnes, Tom Eirik ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Rigshospitalet   (Denmark)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Activation; Complement; Lectin pathway; Mannose binding lectin

Indexed keywords

COMPLEMENT COMPONENT C2; COMPLEMENT MEMBRANE ATTACK COMPLEX; MANNAN; MANNOSE BINDING LECTIN;

ADULT; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT BLOOD LEVEL; COMPLEMENT INHIBITION; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; HUMAN; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; COMPLEMENT C2; COMPLEMENT C4B; COMPLEMENT FACTOR D; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, ALTERNATIVE; HUMANS; MALE; MANNANS; MANNOSE-BINDING LECTIN; SERUM;

EID: 70450223899     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.09.005     Document Type: Article

References (48)

1. Brouwer N., Dolman K.M., van H.M., Sta M., Roos D., and Kuijpers T.W. Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding. J. Immunol. 180 (2008) 4124-4132
2. Brouwer N., Dolman K.M., van Z.R., Nieuwenhuys E., Hart M., Aarden L.A., Roos D., and Kuijpers T.W. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol. Immunol. 43 (2006) 2051-2060
3. Collard C.D., Vakeva A., Morrissey M.A., Agah A., Rollins S.A., Reenstra W.R., Buras J.A., Meri S., and Stahl G.L. Complement activation after oxidative stress: role of the lectin complement pathway. Am. J. Pathol. 156 (2000) 1549-1556
4. Cortesio C.L., and Jiang W. Mannan-binding lectin-associated serine protease 3 cleaves synthetic peptides and insulin-like growth factor-binding protein 5. Arch. Biochem. Biophys. 449 (2006) 164-170
5. Degn S.E., Thiel S., and Jensenius J.C. New perspectives on mannan-binding lectin-mediated complement activation. Immunobiology 212 (2007) 301-311
6. Deguchi M., Gillin F.D., and Gigli I. Mechanism of killing of Giardia lamblia trophozoites by complement. J. Clin. Invest. 79 (1987) 1296-1302
7. Dumestre-Perard C., Lamy B., Aldebert D., Lemaire-Vieille C., Grillot R., Brion J.P., Gagnon J., and Cesbron J.Y. Aspergillus conidia activate the complement by the mannan-binding lectin C2 bypass mechanism. J. Immunol. 181 (2008) 7100-7105
8. Endo M., Ohi H., Ohsawa I., Fujita T., and Matsushita M. Complement activation through the lectin pathway in patients with Henoch-Schonlein purpura nephritis. Am. J. Kidney Dis. 35 (2000) 401-407
9. Endo M., Ohi H., Ohsawa I., Fujita T., Matsushita M., and Fujita T. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol. Dial. Transplant. 13 (1998) 1984-1990
10. Farries T.C., Steuer K.L., and Atkinson J.P. The mechanism of activation of the alternative pathway of complement by cell-bound C4b. Mol. Immunol. 27 (1990) 1155-1161
11. Fung M., Loubser P.G., Undar A., Mueller M., Sun C., Sun W.N., Vaughn W.K., and Fraser Jr. C.D. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J. Thorac. Cardiovasc. Surg. 122 (2001) 113-122
12. Garred P., Larsen F., Madsen H.O., and Koch C. Mannose-binding lectin deficiency-revisited. Mol. Immunol. 40 (2003) 73-84
13. Harboe M., Closs O., Reitan L.J., and Draper P. Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7. Int. J. Lepr. Other Mycobact. Dis. 49 (1981) 147-158
14. Harboe M., and Mollnes T.E. The alternative complement pathway revisited. J. Cell Mol. Med. 12 (2008) 1074-1084
15. Harboe M., Ulvund G., Vien L., Fung M., and Mollnes T.E. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin. Exp. Immunol. 138 (2004) 439-446
16. Harboe M., Garred P., Borgen M.S., Stahl G.L., Roos A., and Mollnes T.E. Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Clin. Exp. Immunol. 144 (2006) 512-520
17. Hisano S., Matsushita M., Fujita T., Endo Y., and Takebayashi S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am. J. Kidney Dis. 38 (2001) 1082-1088
18. Hopp T.P., and Woods K.R. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 3824-3828
19. Hourcade D.E. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J. Biol. Chem. 281 (2006) 2128-2132
20. Iwaki D., Kanno K., Takahashi M., Endo Y., Lynch N.J., Schwaeble W.J., Matsushita M., Okabe M., and Fujita T. Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway. J. Immunol. 177 (2006) 8626-8632
21. Johnson C.A., Densen P., Hurford Jr. R.K., Colten H.R., and Wetsel R.A. Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J. Biol. Chem. 267 (1992) 9347-9353
22. Kimura Y., Miwa T., Zhou L., and Song W.C. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111 (2008) 732-740
23. Knutzen Steuer K.L., Sloan L.B., Oglesby T.J., Farries T.C., Nickells M.W., Densen P., Harley J.B., and Atkinson J.P. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement. J. Immunol. 143 (1989) 2256-2261
24. Krarup A., Thiel S., Hansen A., Fujita T., and Jensenius J.C. L-ficolin is a pattern recognition molecule specific for acetyl groups. J. Biol. Chem. 279 (2004) 47513-47519
25. Larsen F., Madsen H.O., Sim R.B., Koch C., and Garred P. Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J. Biol. Chem. 279 (2004) 21302-21311
26. Larsson K., Wester K., Nilsson P., Uhlen M., Hober S., and Wernerus H. Multiplexed PrEST immunization for high-throughput affinity proteomics. J. Immunol. Methods 315 (2006) 110-120
27. Laursen I., Houen G., Hojrup P., Brouwer N., Krogsoe L.B., Blou L., and Hansen P.R. Second-generation nanofiltered plasma-derived mannan-binding lectin product: process and characteristics. Vox Sang. 92 (2007) 338-350
28. Matsushita M., and Fujita T. Ficolins and the lectin complement pathway. Immunol. Rev. 180 (2001) 78-85
29. Matsushita M., and Okada H. Alternative complement pathway activation by C4b deposited during classical pathway activation. J. Immunol. 136 (1986) 2994-2998
30. Matsuda M., Shikata K., Wada J., Sugimoto H., Shikata Y., Kawasaki T., and Makino H. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron 80 (1998) 408-413
31. McGrath F.D., Brouwer M.C., Arlaud G.J., Daha M.R., Hack C.E., and Roos A. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J. Immunol. 176 (2006) 2950-2957
32. Mollnes T.E., Lea T., Froland S.S., and Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand. J. Immunol. 22 (1985) 197-202
33. Mollnes T.E., Redl H., Hogasen K., Bengtsson A., Garred P., Speilberg L., Lea T., Oppermann M., Gotze O., and Schlag G. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin. Exp. Immunol. 91 (1993) 295-300
34. Oortwijn B.D., Eijgenraam J.W., Rastaldi M.P., Roos A., Daha M.R., and van K.C. The role of secretory IgA and complement in IgA nephropathy. Semin. Nephrol. 28 (2008) 58-65
35. Oortwijn B.D., Roos A., Royle L., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Eijgenraam J.W., Dwek R.A., Daha M.R., Rudd P.M., and van K.C. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. J. Am. Soc. Nephrol. 17 (2006) 3529-3539
36. Persson A., Hober S., and Uhlen M. A human protein atlas based on antibody proteomics. Curr. Opin. Mol. Ther. 8 (2006) 185-190
37. Phillips A.E., Toth J., Dodds A.W., Girija U.V., Furze C.M., Pala E., Sim R.B., Reid K.B., Schwaeble W.J., Schmid R., Keeble A.H., and Wallis R. Analogous interactions in initiating complexes of the classical and lectin pathways of complement. J. Immunol. 182 (2009) 7708-7717
38. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Stahl G.M., and Daha M.R. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167 (2001) 2861-2868
39. Roos A., Rastaldi M.P., Calvaresi N., Oortwijn B.D., Schlagwein N., van Gijlswijk-Janssen D.J., Stahl G.L., Matsushita M., Fujita T., van K.C., and Daha M.R. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J. Am. Soc. Nephrol. 17 (2006) 1724-1734
40. Seelen M.A., Roos A., Wieslander J., Mollnes T.E., Sjoholm A.G., Wurzner R., Loos M., Tedesco F., Sim R.B., Garred P., Alexopoulos E., Turner M.W., and Daha M.R. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J. Immunol. Methods 296 (2005) 187-198
41. Selander B., Martensson U., Weintraub A., Holmstrom E., Matsushita M., Thiel S., Jensenius J.C., Truedsson L., and Sjoholm A.G. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J. Clin. Invest. 116 (2006) 1425-1434
42. Sorensen R., Thiel S., and Jensenius J.C. Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin. Immunopathol. 27 (2005) 299-319
43. Spitzer D., Mitchell L.M., Atkinson J.P., and Hourcade D.E. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J. Immunol. 179 (2007) 2600-2608
44. Stover C.M., Luckett J.C., Echtenacher B., Dupont A., Figgitt S.E., Brown J., Mannel D.N., and Schwaeble W.J. Properdin plays a protective role in polymicrobial septic peritonitis. J. Immunol. 180 (2008) 3313-3318
45. Suankratay C., Zhang X.H., Zhang Y., Lint T.F., and Gewurz H. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J. Immunol. 160 (1998) 3006-3013
46. Takahashi M., Mori S., Shigeta S., and Fujita T. Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway. Adv. Exp. Med. Biol. 598 (2007) 93-104
47. Wagner E., Platt J.L., Howell D.N., Marsh Jr. H.C., and Frank M.M. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model. J. Immunol. 163 (1999) 3549-3558
48. Zhao H., Wakamiya N., Suzuki Y., Hamonko M.T., and Stahl G.L. Identification of human mannose binding lectin (MBL) recognition sites for novel inhibitory antibodies. Hybrid. Hybridomics. 21 (2002) 25-36